Tevogen Bio Holdings Inc.
For the period ended Dec 31, 2025. Filed Mar 31, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 31, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
Our corporate headquarters are located in Warren Township, New Jersey, and consist of 13,242 square feet dedicated to corporate, operational, and pre-commercial activities under a lease that expires February 28, 2033. We also have one research and development facility located in Philadelphia, which is a shared facility with laboratory space dedicated to us that is focused on preclinical and pharmacodynamic activities.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.